Anti-human TL1A [MTLG6 ]

Description:

Recombinant monoclonal antibody to human TL1A. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma MTLG6 .

Clone Name:

MTLG6

Published Application(s):

FACS, WB, ELISA, IF, IHC

Published Species Reactivity:

Human

Products based on this clone:

{{heading}}

Please Select

Ab04202-3.0 Anti-human TL1A [MTLG6 ]
Human
Mouse IgG2b
Purified
Ships in 5-6 weeks

Ab04202-3.3 Anti-human TL1A [MTLG6 ]
Human
Mouse IgG2b
Fc Silent™
Purified
Ships in 5-6 weeks

Ab04202-23.0 Anti-human TL1A [MTLG6 ]
Human
Rabbit IgG
Purified
Ships in 5-6 weeks

UniProt Accession Number of Target Protein: O95150

Alternative Name(s) of Target: MTLA5; TL1; TNF-like ligand 1A; Tumor necrosis factor superfamily member 15; TNF superfamily member 15; TNFSF15; Vascular endothelial growth inhibitor; VEGI; VEGI192A; TNLG1B

Specificity: This antibody is specific for human TL1A.

Application Notes: The original format of this antibody (mouse IgG2b, κ) was used to detect human TL1A in WB, IHC, and IF (Bamias et al., 2011; PMID: 21672030). Furthermore, the biotinylated version of this antibody was used to detect human TL1A in a quantitative ELISA (Kim et al., 2012; PMID: 22647538). This antibody is suitable for use in FACS (unpublished results of Dr. Sunghee Kim).

Antibody first published in: Kim et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis Diagn Microbiol Infect Dis. 2012 Aug;73(4):312-7. doi: 10.1016/j.diagmicrobio.2012.04.008 PMID:22647538
Note on publication: The original publication investigates the potential of soluble decoy receptor 3 (DcR3) as a clinically important biomarker for sepsis.